The Economic Burden of Osteoporosis

Osteoporosis is the most common metabolic bone disorder; through its prevalence and utilization of healthcare resources, the disease creates an enormous medical and economic burden that is set to worsen based on current population predictions. The transition of US healthcare from a volume-based to value-based reimbursement system presents an opportunity to address large population health problems such as osteoporosis. By reorganizing treatment plans and outcomes around the needs of the patient, the burden of osteoporosis can be managed in a more cost-effective way.